Balchem Price to Sales Ratio vs Gross Profit Analysis

BCPC Stock

USD 145.62 1.14 0.78%

Balchem financial indicator trend analysis is way more than just evaluating Balchem prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Balchem is a good investment. Please check the relationship between Balchem Price To Sales Ratio and its Gross Profit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.

Price To Sales Ratio vs Gross Profit

Price to Sales Ratio vs Gross Profit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Balchem Price to Sales Ratio account and Gross Profit. At this time, the significance of the direction appears to have strong relationship.

The correlation between Balchem's Price to Sales Ratio and Gross Profit is 0.69. Overlapping area represents the amount of variation of Price to Sales Ratio that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Balchem, assuming nothing else is changed. The correlation between historical values of Balchem's Price to Sales Ratio and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price to Sales Ratio of Balchem are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Price to Sales Ratio i.e., Balchem's Price to Sales Ratio and Gross Profit go up and down completely randomly.

Correlation Coefficient

0.69

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Balchem stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Balchem sales, a figure that is much harder to manipulate than other Balchem multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Balchem minus its cost of goods sold. It is profit before Balchem operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most indicators from Balchem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Balchem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.At present, Balchem's Enterprise Value Over EBITDA is projected to increase based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 22.77, whereas Tax Provision is forecasted to decline to about 24.2 M.

	2021	2022	2023	2024 (projected)
Gross Profit	243.2M	280.5M	302.1M	317.2M
Total Revenue	799.0M	942.4M	922.4M	968.6M

Gross Profit Total Revenue

Balchem fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Cash	Cash And Short Term Investments	Non Currrent Assets Other	Accounts Payable	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.83	0.82	0.96	0.97	0.99	0.77	0.96	0.99	0.97	0.61	0.89	0.98	0.17	0.84	0.93	0.92	0.78	-0.28	-0.29	-0.29	-0.23	0.92	0.93	0.51	0.48
Short Long Term Debt Total	0.83		0.61	0.8	0.67	0.77	0.97	0.66	0.86	0.74	0.45	0.99	0.77	0.3	0.62	0.98	0.69	0.46	0.02	-0.47	-0.47	-0.32	0.67	0.97	0.39	0.36
Other Current Liab	0.82	0.61		0.87	0.82	0.84	0.57	0.8	0.8	0.88	0.66	0.67	0.83	0.0	0.79	0.73	0.64	0.7	-0.22	-0.2	-0.2	-0.37	0.79	0.72	0.54	0.54
Total Current Liabilities	0.96	0.8	0.87		0.93	0.95	0.74	0.92	0.96	0.96	0.62	0.84	0.95	0.22	0.81	0.9	0.88	0.75	-0.19	-0.29	-0.29	-0.21	0.94	0.89	0.52	0.49
Total Stockholder Equity	0.97	0.67	0.82	0.93		0.98	0.6	1.0	0.95	0.97	0.63	0.75	0.97	0.09	0.85	0.81	0.93	0.85	-0.38	-0.17	-0.17	-0.17	0.92	0.81	0.52	0.48
Property Plant And Equipment Net	0.99	0.77	0.84	0.95	0.98		0.72	0.97	0.98	0.98	0.62	0.84	0.98	0.14	0.87	0.89	0.91	0.77	-0.35	-0.29	-0.29	-0.23	0.92	0.88	0.5	0.47
Net Debt	0.77	0.97	0.57	0.74	0.6	0.72		0.59	0.82	0.67	0.31	0.95	0.71	0.33	0.57	0.93	0.64	0.27	-0.06	-0.68	-0.68	-0.37	0.61	0.94	0.23	0.2
Retained Earnings	0.96	0.66	0.8	0.92	1.0	0.97	0.59		0.94	0.96	0.58	0.75	0.98	0.07	0.8	0.81	0.94	0.85	-0.42	-0.16	-0.16	-0.15	0.94	0.8	0.48	0.44
Non Current Assets Total	0.99	0.86	0.8	0.96	0.95	0.98	0.82	0.94		0.96	0.56	0.91	0.97	0.2	0.82	0.95	0.92	0.7	-0.29	-0.39	-0.39	-0.25	0.9	0.95	0.45	0.42
Net Receivables	0.97	0.74	0.88	0.96	0.97	0.98	0.67	0.96	0.96		0.69	0.8	0.98	0.18	0.87	0.86	0.87	0.82	-0.3	-0.23	-0.23	-0.27	0.95	0.86	0.58	0.55
Common Stock Shares Outstanding	0.61	0.45	0.66	0.62	0.63	0.62	0.31	0.58	0.56	0.69		0.48	0.59	0.18	0.8	0.53	0.41	0.75	0.13	0.27	0.27	-0.17	0.54	0.55	0.97	0.98
Non Current Liabilities Total	0.89	0.99	0.67	0.84	0.75	0.84	0.95	0.75	0.91	0.8	0.48		0.84	0.28	0.67	0.99	0.75	0.53	-0.08	-0.45	-0.45	-0.3	0.74	0.99	0.41	0.38
Inventory	0.98	0.77	0.83	0.95	0.97	0.98	0.71	0.98	0.97	0.98	0.59	0.84		0.13	0.8	0.89	0.9	0.81	-0.38	-0.25	-0.25	-0.25	0.96	0.87	0.48	0.45
Other Current Assets	0.17	0.3	0.0	0.22	0.09	0.14	0.33	0.07	0.2	0.18	0.18	0.28	0.13		0.24	0.28	0.09	-0.01	0.26	-0.27	-0.27	0.02	0.18	0.29	0.16	0.16
Other Stockholder Equity	0.84	0.62	0.79	0.81	0.85	0.87	0.57	0.8	0.82	0.87	0.8	0.67	0.8	0.24		0.72	0.69	0.68	-0.12	-0.19	-0.19	-0.28	0.71	0.75	0.68	0.68
Total Liab	0.93	0.98	0.73	0.9	0.81	0.89	0.93	0.81	0.95	0.86	0.53	0.99	0.89	0.28	0.72		0.8	0.6	-0.1	-0.43	-0.43	-0.29	0.8	0.99	0.44	0.41
Property Plant And Equipment Gross	0.92	0.69	0.64	0.88	0.93	0.91	0.64	0.94	0.92	0.87	0.41	0.75	0.9	0.09	0.69	0.8		0.71	-0.35	-0.28	-0.28	-0.04	0.87	0.8	0.34	0.27
Total Current Assets	0.78	0.46	0.7	0.75	0.85	0.77	0.27	0.85	0.7	0.82	0.75	0.53	0.81	-0.01	0.68	0.6	0.71		-0.16	0.36	0.36	-0.03	0.8	0.57	0.7	0.68
Short Term Debt	-0.28	0.02	-0.22	-0.19	-0.38	-0.35	-0.06	-0.42	-0.29	-0.3	0.13	-0.08	-0.38	0.26	-0.12	-0.1	-0.35	-0.16		0.28	0.28	0.11	-0.37	-0.09	0.2	0.24
Cash	-0.29	-0.47	-0.2	-0.29	-0.17	-0.29	-0.68	-0.16	-0.39	-0.23	0.27	-0.45	-0.25	-0.27	-0.19	-0.43	-0.28	0.36	0.28		1.0	0.33	-0.21	-0.45	0.36	0.38
Cash And Short Term Investments	-0.29	-0.47	-0.2	-0.29	-0.17	-0.29	-0.68	-0.16	-0.39	-0.23	0.27	-0.45	-0.25	-0.27	-0.19	-0.43	-0.28	0.36	0.28	1.0		0.33	-0.21	-0.45	0.36	0.38
Non Currrent Assets Other	-0.23	-0.32	-0.37	-0.21	-0.17	-0.23	-0.37	-0.15	-0.25	-0.27	-0.17	-0.3	-0.25	0.02	-0.28	-0.29	-0.04	-0.03	0.11	0.33	0.33		-0.19	-0.29	-0.09	-0.12
Accounts Payable	0.92	0.67	0.79	0.94	0.92	0.92	0.61	0.94	0.9	0.95	0.54	0.74	0.96	0.18	0.71	0.8	0.87	0.8	-0.37	-0.21	-0.21	-0.19		0.78	0.44	0.4
Intangible Assets	0.93	0.97	0.72	0.89	0.81	0.88	0.94	0.8	0.95	0.86	0.55	0.99	0.87	0.29	0.75	0.99	0.8	0.57	-0.09	-0.45	-0.45	-0.29	0.78		0.46	0.43
Common Stock Total Equity	0.51	0.39	0.54	0.52	0.52	0.5	0.23	0.48	0.45	0.58	0.97	0.41	0.48	0.16	0.68	0.44	0.34	0.7	0.2	0.36	0.36	-0.09	0.44	0.46		0.99
Common Stock	0.48	0.36	0.54	0.49	0.48	0.47	0.2	0.44	0.42	0.55	0.98	0.38	0.45	0.16	0.68	0.41	0.27	0.68	0.24	0.38	0.38	-0.12	0.4	0.43	0.99

Click cells to compare fundamentals

Balchem Account Relationship Matchups

Balchem fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.2B	1.2B	1.2B	1.6B	1.6B	1.7B
Short Long Term Debt Total	248.6M	163.6M	108.6M	440.6M	330.3M	346.9M
Other Current Liab	52.5M	68.3M	85.2M	78.7M	58.1M	61.0M
Total Current Liabilities	92.3M	94.4M	143.8M	140.0M	148.5M	155.9M
Total Stockholder Equity	743.7M	828.2M	877.0M	938.3M	1.1B	1.1B
Property Plant And Equipment Net	224.2M	236.5M	246.8M	290.8M	295.9M	310.7M
Net Debt	182.9M	79.0M	5.3M	374.0M	265.9M	279.2M
Retained Earnings	590.9M	656.7M	732.1M	814.5M	897.5M	942.4M
Non Current Assets Total	900.7M	899.0M	877.1M	1.3B	1.3B	1.4B
Net Receivables	93.4M	98.2M	117.4M	131.6M	125.3M	131.5M
Common Stock Shares Outstanding	32.5M	32.5M	32.7M	32.4M	32.4M	30.0M
Liabilities And Stockholders Equity	1.2B	1.2B	1.2B	1.6B	1.6B	1.7B
Non Current Liabilities Total	319.8M	243.2M	178.5M	546.2M	422.7M	443.8M
Inventory	83.9M	70.6M	91.1M	119.7M	109.5M	115.0M
Other Current Assets	11.9M	13.5M	10.5M	18.0M	15.0M	15.7M
Other Stockholder Equity	156.1M	165.2M	147.7M	128.8M	145.7M	152.9M
Total Liab	412.0M	337.6M	322.3M	686.2M	571.2M	599.7M
Property Plant And Equipment Gross	224.2M	236.5M	246.8M	290.8M	508.7M	534.1M
Total Current Assets	254.9M	266.9M	322.2M	335.8M	314.2M	330.0M
Accumulated Other Comprehensive Income	(5.6M)	4.2M	(5.0M)	(7.2M)	8.7M	9.1M
Cash	65.7M	84.6M	103.2M	66.6M	64.4M	46.2M
Cash And Short Term Investments	65.7M	84.6M	103.2M	66.6M	64.4M	46.2M
Non Currrent Assets Other	8.6M	11.3M	11.7M	(52.0M)	12.9M	13.5M
Accounts Payable	37.3M	23.7M	56.2M	57.3M	55.5M	58.3M
Intangible Assets	143.9M	121.7M	94.7M	213.3M	191.2M	200.8M
Common Stock Total Equity	2.2M	2.2M	2.2M	2.1M	2.5M	1.6M
Common Stock	2.2M	2.2M	2.2M	2.1M	2.2M	1.6M
Other Liab	64.6M	68.0M	69.9M	89.6M	103.0M	108.2M
Property Plant Equipment	216.9M	228.1M	246.8M	271.4M	312.1M	327.7M
Long Term Debt	256.4M	174.1M	108.6M	440.6M	309.6M	325.0M
Good Will	524.0M	529.5M	523.9M	769.5M	778.9M	817.9M
Other Assets	4.1M	19.7M	11.7M	10.8M	12.4M	13.1M
Net Tangible Assets	75.7M	298.8M	258.4M	168.8M	194.1M	129.0M
Retained Earnings Total Equity	590.9M	656.7M	732.1M	814.5M	936.7M	469.1M
Long Term Debt Total	163.4M	256.4M	174.1M	122.3M	140.6M	173.3M
Capital Surpluse	174.2M	173.0M	147.7M	128.8M	148.1M	135.9M
Deferred Long Term Liab	58.5M	51.4M	46.5M	62.8M	72.2M	43.5M

Pair Trading with Balchem

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Balchem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Balchem will appreciate offsetting losses from the drop in the long position's value.

Moving together with Balchem Stock

0.84

DNMR

Danimer Scientific Financial Report 8th of May 2024

Pair Corr

Moving against Balchem Stock

0.61

Chemours Earnings Call Next Week

Pair Corr

The ability to find closely correlated positions to Balchem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Balchem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Balchem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Balchem to buy it.

The correlation of Balchem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Balchem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Balchem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Balchem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Balchem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Balchem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Balchem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Balchem Stock:

How To Invest In Balchem

Details

Is Balchem Stock a good investment?

Details

What is Balchem's Net Worth?

Details

Largest Specialty Chemicals Companies

View

Largest Basic Materials Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.

You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Balchem Stock analysis

When running Balchem's price analysis, check to measure Balchem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Balchem is operating at the current time. Most of Balchem's value examination focuses on studying past and present price action to predict the probability of Balchem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Balchem's price. Additionally, you may evaluate how the addition of Balchem to your portfolios can decrease your overall portfolio volatility.

	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	CEOs Directory Screen CEOs from public companies around the world
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account

Is Balchem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.243

Dividend Share

0.79

Earnings Share

3.34

Revenue Per Share

28.729

Quarterly Revenue Growth

(0.02)

The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Balchem Price to Sales Ratio vs Gross Profit Analysis

Price To Sales Ratio vs Gross Profit

Price to Sales Ratio vs Gross Profit Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Gross Profit

Balchem fundamental ratios Correlations

Balchem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Balchem fundamental ratios Accounts

Pair Trading with Balchem

Moving together with Balchem Stock

Moving against Balchem Stock

Complementary Tools for Balchem Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Net	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Non Current Liabilities Total

Cash And Short Term Investments	- 0.68	Net Debt
Cash	- 0.68	Net Debt
Cash And Short Term Investments	- 0.47	Short Long Term Debt Total
Cash	- 0.47	Short Long Term Debt Total
Intangible Assets	- 0.45	Cash And Short Term Investments
Intangible Assets	- 0.45	Cash